• Immunogenicity Assessment

    • Therapeutic In Silico Services
      • ISPRIâ„¢ Website
      • ISPRI Downselectâ„¢
      • ISPRI Quantifyâ„¢
      • ISPRI Analyzeâ„¢
      • ISPRI Evaluateâ„¢
      • ISPRI-HCPâ„¢
      • ISPRI Designâ„¢
      • PANDA® Screening
    • Vaccine In Silico Services
      • iVAXâ„¢
      • EpiCCâ„¢
      • Ancer®
      • PreVAXâ„¢
    • Lab Services
      • All In Vitro Assays
      • Generic Peptide PANDA® Assays
    • Consulting Services
      • Trusted Expert Advice (TEA)
      • IRA / ISI Regulatory Writing Support
    • Why Immunogenicity Risk Assessment?
    • Why EpiVax?
  • About Us
    • Company History
    • Leadership
    • Careers
  • Press
    • News
    • Events
    • Publications
    • Blog
  • Contact Us
HelicoVax: Epitope-based therapeutic H. pylori vaccination in a mouse model of gastric cancer

HelicoVax: Epitope-based therapeutic H. pylori vaccination in a mouse model of gastric cancer

by Adam | Oct 22, 2016

Vaccine. 2011. Mar 3;29(11):2085-91
An Integrated Genomic and Immunoinformatic Approach to H. pylori Vaccine Design. 2011

An Integrated Genomic and Immunoinformatic Approach to H. pylori Vaccine Design. 2011

by Adam | Oct 22, 2016

Immunome Research. Vol 7, No 2 (2011). https://immunome-research.net/journal/index.php/immunome.
Human immune responses to H. pylori HLA Class II epitopes identified by immunoinformatic methods

Human immune responses to H. pylori HLA Class II epitopes identified by immunoinformatic methods

by Adam | Oct 22, 2016

PlosOne. 2014 Apr 16. Full Text

Recent Posts

  • EpiVax Announces Laboratory Expansion and Streamlined, NAM-Centric In Vitro Services    
  • Replacing Animal Models with Human-Relevant New Approach Methodologies (NAMs) for Immunogenicity in Clinic
  • EpiVax Enters its Next Chapter with SV Health Investors
  • Immunogenicity Risk Assessment Outputs to Drive a Streamlined, Risk-Based Preclinical and Clinical Strategy
  • Immunogenicity Risk Assessment Outputs to Drive a Streamlined, Risk-Based Preclinical and Clinical Strategy

Recent Comments

  1. Homepage on Doing Well and Giving Back in December

Explore

Therapeutic In Silico Services

Vaccine In Silico Services

Lab Services

Consulting

LinkedIn

About Us

Careers

News

Events

Publications

Contact Us

We use cookies to ensure that we give you the best experience on our website. By clicking 'accept', you consent to our use of cookies.